Medicus Pharma
MDCX
21 hedge funds and large institutions have $6.6M invested in Medicus Pharma in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
433% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 3
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
163% more funds holding
Funds holding: 8 → 21 (+13)
8.92% less ownership
Funds ownership: 22.77% → 13.85% (-8.9%)
59% less capital inflows, than outflows
Capital inflows: $2.1M | Capital outflows: $5.12M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Private Advisor Group
Morristown,
New Jersey
|
+$356K |
| 2 |
Guyasuta Investment Advisors
Pittsburgh,
Pennsylvania
|
+$307K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$213K |
| 4 |
SeaCrest Wealth Management
Purchase,
New York
|
+$186K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$4.71M |
| 2 |
Interchange Capital Partners
Pittsburgh,
Pennsylvania
|
-$300K |
| 3 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
-$109K |
| 4 |
HCAL
HURRICANE CAPITAL ADVISORS LLC
New York
|
-$6.44K |
MDCX Hedge Fund Activity: Q2 2025 in Review
21 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma (MDCX) for Q2 2025, worth a combined $6.6M — down 42% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new MDCX positions and 3 closed out — a net gain of 13 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Private Advisor Group, adding an estimated $356K. The largest seller was Armistice Capital, exiting entirely with an estimated $4.71M sold.
- 21 institutional investors held Medicus Pharma (MDCX) as of Q2 2025, up from 8 in Q1 2025.
- Funds reported $6.6M of Medicus Pharma stock for Q2 2025, down 42% quarter-over-quarter.
- 16 funds opened new Medicus Pharma positions in Q2 2025 and 3 closed out, a net change of +13 holders.
- The largest Medicus Pharma buyer in Q2 2025 was Private Advisor Group, an estimated $356K added.
- The largest Medicus Pharma seller in Q2 2025 was Armistice Capital, an estimated $4.71M sold.
Based on aggregated 13F filings for Q2 2025.